TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nordic Drugs AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
337,525
|
300,076
|
240,041 |
Financial expenses |
14
|
75
|
112 |
Earnings before taxes |
14,904
|
-2,971
|
-3,427 |
EBITDA |
14,100
|
-3,923
|
-4,432 |
Total assets |
170,179
|
139,098
|
148,441 |
Current assets |
169,078
|
136,687
|
144,817 |
Current liabilities |
67,440
|
45,916
|
49,744 |
Equity capital |
97,900
|
88,366
|
92,292 |
- share capital |
20,000
![]() |
20,000
![]() |
20,000 |
Employees (average) |
25
|
26
![]() |
26 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
57.5%
|
63.5%
|
62.2% |
Turnover per employee |
13,501
|
11,541
|
9,232 |
Profit as a percentage of turnover |
4.4%
|
-1.0%
|
-1.4% |
Return on assets (ROA) |
8.8%
|
-2.1%
|
-2.2% |
Current ratio |
250.7%
|
297.7%
|
291.1% |
Return on equity (ROE) |
15.2%
|
-3.4%
|
-3.7% |
Change turnover |
37,449
|
60,035
|
-45,990 |
Change turnover % |
12%
|
25%
|
-16% |
Chg. No. of employees |
-1
|
0
|
-1 |
Chg. No. of employees % |
-4%
|
0%
|
-4% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.